LeMaitre to Present at Upcoming Investor Conferences

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its participation in two investor conferences in August 2021.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its participation in two investor conferences in August 2021. CFO JJ Pellegrino will present at the Canaccord Genuity 41st Annual Growth Conference on August 12 at 9:00 AM EDT and will also attend the Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16. LeMaitre specializes in devices and services for treating peripheral vascular disease, which impacts over 200 million people globally.

Argus Session date unavailable

+1.83% session move Open Argus

Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was +1.83%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/06/2021 - 11:07 AM

BURLINGTON, Mass., Aug. 06, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the virtual Canaccord Genuity 41^st Annual Growth Conference on Thursday, August 12, 2021, at 9:00 AM EDT.

He is also scheduled to participate in the 6^th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Monday, August 16, 2021.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the dates of the investor conferences for LeMaitre Vascular in August 2021?

LeMaitre Vascular will participate in two conferences: the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021, and the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2021.

Who will present on behalf of LeMaitre Vascular at the investor conferences?

JJ Pellegrino, the Chief Financial Officer, will present at both investor conferences in August 2021.

What is the primary focus of LeMaitre Vascular's business?

LeMaitre Vascular focuses on developing, manufacturing, and marketing devices for the treatment of peripheral vascular disease.

How many people are affected by peripheral vascular disease worldwide?

Peripheral vascular disease affects more than 200 million people globally.

Where can I find more information about LeMaitre Vascular?

Additional information about LeMaitre Vascular can be found on their website at www.lemaitre.com.

Keep reading

Trending in the feed

AMTM

Amentum Joint Venture Secures Preferred Position for Major UK Nuclear Contract Open the live feed